Samsara BioCapital, LLC

Q1 2023 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Miran Ahmad - Chief Financial Officer
Location
Palo Alto, CA
Holdings as of
March 31, 2023
Value $
$484M
Num holdings
56
Date filed
8/14/2023, 04:57 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q4 2022 - Feb 14, 2023
Next filing
Q2 2023 - Aug 14, 2023
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2023 Q1 - Restatement compared to 2022 Q4 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Miran Ahmad Chief Financial Officer Palo Alto, California 8/14/2023

This amendment filing is a restatement of the values in the information table and the information table entry total included in the Report Summary and supersedes the prior filing.